US industry buoyed by Congress moves
This article was originally published in Clinica
Executive Summary
US medical device makers are riding a fairly high wave in Congress at present, with Congress poised to finalise in a matter of weeks a bill that would solidify a five-year agreement allowing the Food and Drug Administration to collect user fees from the device industry in exchange for faster and more predictable product reviews. In addition, federal legislators are considering a substantial increase in the FDA's budget, including increases for review of medical devices.